Trade Secretary Cristina Roque reported on Saturday that the British-Swedish pharmaceutical AstraZeneca expressed interest in ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...

Having ADHD is associated with a shorter life expectancy and a greater risk of mental health issues, according to a new study ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

People spend approximately 90 percent of their time indoors where most respiratory infections—a leading cause of death globally—are transmitted. Ultraviolet energy at germicidal wavelengths has the ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

The FDA has removed a draft guidance that mandated diverse testing of medicines and devices, following directives from the Trump administration to dismantle diversity initiatives. The move raises ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.